AETHLON MEDICAL INC AEMD
Key Stats
- Today's Range
- $2.17 – $2.35
- 50-Day Range
- $2.17 – $9.85
- 52-Week Range
- $2.17 – $137.00
- Volume
- 16.55 million shs
- Average Volume
- 600K shs
- Market Cap
- $1.62 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.31
- Price / Sales
- 2136.22
Short Interest
- Short Interest
- 176.25%
- Days to Cover
- 3.47
Financials (TTM)
- Revenue
- $759
- Net Income
- $-6,937,523
- Net Margin
- -914034.65%
- Return on Equity
- -133.43%
- Debt-to-Equity
- —
About AETHLON MEDICAL INC
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Related Stocks
Compare head-to-head: AEMD vs SYK·AEMD vs BSX·AEMD vs RMD·AEMD vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.